CL Colgate Palmolive Co stock chart & analysis
Conviction 42Consumer StaplesScan · Fri, Nov 6, 2026Colgate Palmolive Co (CL) closed at $96.56 (-2.16%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 85, -4.6% from its 52-week high, +22.2% year to date. Sector: Consumer Staples · Perfumes, Cosmetics & Other Toilet Preparations.
Financials as of Wed, Sep 30, 2026 · quarterly.
CL technical analysis
Trend
CL is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 7.1% above the 50-day ($90.14) and 7.3% above the 200-day ($89.99). The 50-day crossed above the 200-day (a golden cross) 2 sessions ago. ADX(14) at 40 points to a strong, established trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 59, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 85 puts its weighted 12-month performance ahead of about 85% of the US market.
Volume and volatility
Volume on the latest session ran 0.8× its 20-day average. It trades about $482.3M a day on average. ATR(14) is $2.36, 2.4% of price — its typical daily range. Chaikin Money Flow (0.05) shows accumulation.
Key levels
The chart pattern's support is $84.52 and its resistance $97.94. The 52-week range is $75.96 to $101.18; price is 4.6% below the high and 27.1% above the low. The VWAP anchored at the 52-week high is $98.30, above price.
Performance
CL returned +1.3% (1 week), +9.6% (1 month), +3.6% (3 months), +10.3% (6 months), +25.5% (1 year), +22.2% (year to date).
About Colgate Palmolive Co
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
Perfumes, Cosmetics & Other Toilet Preparations · Listed 1951 · 33,600 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upOct 5 – Oct 73 scans
- Breaking out nowOct 81 scan
- Broke outOct 9 – Oct 155 scans
Congress activity
Disclosed STOCK Act trades in CL · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Kevin Hern house · R · OK · traded 2026-08-27 | Sell | $1K–$15K | 2026-08-27 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-08-31 | Sell | $1K–$15K | 2026-08-31 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-09-02 | Sell | $1K–$15K | 2026-09-02 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-08-19 | Sell | $1K–$15K | 2026-08-19 | 2026-09-01 | |
 Julie Johnson house · D · TX · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2026-08-05 | |
 Lisa McClain house · R · MI · traded 2025-09-11 | Sell | $1K–$15K | 2025-09-11 | 2025-10-22 | |
 Rick Larsen house · D · WA · traded 2025-10-06 | Sell | $1K–$15K | 2025-10-06 | 2025-10-16 | |
 Tim Moore house · R · NC · traded 2025-09-10 | Sell | $1K–$15K | 2025-09-10 | 2025-10-10 | |
Julie Johnson house · D · TX · traded 2025-09-25 | Sell | $1K–$15K | 2025-09-25 | 2025-10-07 | |
Lisa McClain house · R · MI · traded 2025-08-13 | Buy | $1K–$15K | 2025-08-13 | 2025-09-12 |
Insider activity
SEC Form 4 transactions in CL · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Wallace Noel R. Chairman, President & CEO · Common Stock · 2026-11-05 | Sell | 20K | $2.0M | 2026-11-05 | 2026-11-06 |
Hazlin John Chief Growth Officer · Common Stock · 2026-11-04 | Sell | 23.38K | $2.3M | 2026-11-04 | 2026-11-06 |
Hazlin John Chief Growth Officer · Stock Option (Right to Buy) · 2026-11-04 | Exercise | 23.38K | — | 2026-11-04 | 2026-11-06 |
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin · Common Stock · 2026-11-04 | Exercise | 19.94K | $1.5M | 2026-11-04 | 2026-11-06 |
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin · Common Stock · 2026-11-04 | Sell | 19.94K | $2.0M | 2026-11-04 | 2026-11-06 |
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin · Stock Option (Right to Buy) · 2026-11-04 | Exercise | 19.94K | — | 2026-11-04 | 2026-11-06 |
Hazlin John Chief Growth Officer · Common Stock · 2026-11-04 | Exercise | 23.38K | $1.8M | 2026-11-04 | 2026-11-06 |
BILBREY JOHN P Director · Common Stock · 2026-10-01 | Grant | 271 | $24K | 2026-10-01 | 2026-10-02 |
Malcolm Gregory EVP and Controller · Common Stock · 2026-09-13 | Tax | 225 | $20K | 2026-09-13 | 2026-09-15 |
Fishbone Betsy CLO and Secretary · Common Stock · 2026-09-13 | Tax | 472 | $41K | 2026-09-13 | 2026-09-15 |
SEC filings
EDGAR filings in CL · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.